Literature DB >> 16622244

Cleavage of the N-linked oligosaccharide from the surfaces of Chlamydia species affects infectivity in the mouse model of lung infection.

Lee Ann Campbell1, Amy Lee, Cho-chou Kuo.   

Abstract

Previous studies determined that the Chlamydia glycan contains a high-mannose oligosaccharide, which is involved in attachment and infectivity of the organism, and that removal of the glycan decreases infectivity in vitro. The present study demonstrates that treatment of the organism with N-glycanase decreases or ablates infectivity in vivo.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16622244      PMCID： PMC1459694          DOI： 10.1128/IAI.74.5.3027-3029.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  10 in total

1.  Evidence that the major outer membrane protein of Chlamydia trachomatis is glycosylated.

Authors:  A F Swanson; C C Kuo
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Mechanism of C. trachomatis attachment to eukaryotic host cells.

Authors:  J P Zhang; R S Stephens
Journal:  Cell       Date:  1992-05-29       Impact factor: 41.582

3.  Differences in the association of Chlamydia trachomatis serovar E and serovar L2 with epithelial cells in vitro may reflect biological differences in vivo.

Authors:  C H Davis; P B Wyrick
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  An N-linked high-mannose type oligosaccharide, expressed at the major outer membrane protein of Chlamydia trachomatis, mediates attachment and infectivity of the microorganism to HeLa cells.

Authors:  C Kuo; N Takahashi; A F Swanson; Y Ozeki; S Hakomori
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

5.  Chlamydia trachomatis-host cell interactions: role of the chlamydial major outer membrane protein as an adhesin.

Authors:  H Su; N G Watkins; Y X Zhang; H D Caldwell
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

6.  Entry of genital Chlamydia trachomatis into polarized human epithelial cells.

Authors:  P B Wyrick; J Choong; C H Davis; S T Knight; M O Royal; A S Maslow; C R Bagnell
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

7.  Mannose-receptor positive and negative mouse macrophages differ in their susceptibility to infection by Chlamydia species.

Authors:  Cho-chou Kuo; Mirja Puolakkainen; Tsun-Mei Lin; Marcia Witte; Lee Ann Campbell
Journal:  Microb Pathog       Date:  2002-01       Impact factor: 3.738

8.  Cleavage of the N-linked oligosaccharide from the surfaces of Chlamydia species affects attachment and infectivity of the organisms in human epithelial and endothelial cells.

Authors:  Cho-chou Kuo; Amy Lee; Lee Ann Campbell
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

9.  Murine models of Chlamydia pneumoniae infection and atherosclerosis.

Authors:  T C Moazed; C Kuo; J T Grayston; L A Campbell
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

10.  Molecular characterization and outer membrane association of a Chlamydia trachomatis protein related to the hsp70 family of proteins.

Authors:  J E Raulston; C H Davis; D H Schmiel; M W Morgan; P B Wyrick
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157
  10 in total
  6 in total

1.  Chlamydia pneumoniae induces expression of pro-atherogenic factors through activation of the lectin-like oxidized LDL receptor-1.

Authors:  Lee A Campbell; Amy W Lee; Michael E Rosenfeld; Cho-Chou Kuo
Journal:  Pathog Dis       Date:  2013-10-01       Impact factor: 3.166

2.  Retinoic acid prevents Chlamydia pneumoniae-induced foam cell development in a mouse model of atherosclerosis.

Authors:  Shinn-Jong Jiang; Lee Ann Campbell; Mark W Berry; Michael E Rosenfeld; Cho-Chou Kuo
Journal:  Microbes Infect       Date:  2008-07-17       Impact factor: 2.700

3.  Retinoic acid inhibits the infectivity and growth of Chlamydia pneumoniae in epithelial and endothelial cells through different receptors.

Authors:  Mirja Puolakkainen; Amy Lee; Tadayoshi Nosaka; Hideto Fukushi; Cho-Chou Kuo; Lee Ann Campbell
Journal:  Microb Pathog       Date:  2007-11-23       Impact factor: 3.738

4.  Efficacy of benzoxazinorifamycins in a mouse model of Chlamydia pneumoniae lung infection.

Authors:  Lee Ann Campbell; Cho-Chou Kuo; Robert J Suchland; David M Rothstein
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

Review 5.  Pathogenic Puppetry: Manipulation of the Host Actin Cytoskeleton by Chlamydia trachomatis.

Authors:  Liam Caven; Rey A Carabeo
Journal:  Int J Mol Sci       Date:  2019-12-21       Impact factor: 5.923

Review 6.  Utilization of Galectins by Pathogens for Infection.

Authors:  Diyoly Ayona; Pierre-Edouard Fournier; Bernard Henrissat; Benoit Desnues
Journal:  Front Immunol       Date:  2020-08-19       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.